Literature DB >> 8722681

Morphology and classification of the myelodysplastic syndromes and their pathologic variants.

P A Kouides1, J M Bennett.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8722681

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  10 in total

1.  The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes.

Authors:  Elias Jabbour; Guillermo Garcia-Manero; A Megan Cornelison; Jorge E Cortes; Farhad Ravandi; Naval Daver; Tapan Kadia; Angela Teng; Hagop Kantarjian
Journal:  Leuk Lymphoma       Date:  2014-07-17

2.  NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

Authors:  Peter L Greenberg; Eyal Attar; John M Bennett; Clara D Bloomfield; Carlos M De Castro; H Joachim Deeg; James M Foran; Karin Gaensler; Guillermo Garcia-Manero; Steven D Gore; David Head; Rami Komrokji; Lori J Maness; Michael Millenson; Stephen D Nimer; Margaret R O'Donnell; Mark A Schroeder; Paul J Shami; Richard M Stone; James E Thompson; Peter Westervelt
Journal:  J Natl Compr Canc Netw       Date:  2011-01       Impact factor: 11.908

Review 3.  The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Authors:  John M Bennett; Peter A Kouides; Stephen J Forman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome.

Authors:  Yoo-Jin Kim; Dong-Wook Kim; Seok Lee; Chang-Ki Min; Dong-Gun Lee; Soo-Mi Choi; Ki-Seong Eom; Hee-Je Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 5.  Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).

Authors:  Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R Sperr; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

6.  Atypical CML with massive splenic infarct: an extremely rare presentation.

Authors:  Dhrubajyoti Bandyopadhyay; Satyaki Manna; Adrija Hajra; Tanima Das Bhattacharya
Journal:  BMJ Case Rep       Date:  2015-11-12

7.  Myelodysplastic syndromes: clinical practice guidelines in oncology.

Authors:  Peter L Greenberg; Eyal Attar; John M Bennett; Clara D Bloomfield; Uma Borate; Carlos M De Castro; H Joachim Deeg; Olga Frankfurt; Karin Gaensler; Guillermo Garcia-Manero; Steven D Gore; David Head; Rami Komrokji; Lori J Maness; Michael Millenson; Margaret R O'Donnell; Paul J Shami; Brady L Stein; Richard M Stone; James E Thompson; Peter Westervelt; Benton Wheeler; Dorothy A Shead; Maoko Naganuma
Journal:  J Natl Compr Canc Netw       Date:  2013-07       Impact factor: 11.908

8.  Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia.

Authors:  Kwang Il Ko; Mi Jung Lee; Fa Mee Doh; Hyang Mo Koo; Chan Ho Kim; Dong Ho Shin; Hyung Jung Oh; Seung Hyeok Han; Shin-Wook Kang; Kyu Hun Choi; Tae-Hyun Yoo
Journal:  Kidney Res Clin Pract       Date:  2013-07-10

9.  Impairment of FOS mRNA stabilization following translation arrest in granulocytes from myelodysplastic syndrome patients.

Authors:  Xiaomin Feng; Yayoi Shikama; Tsutomu Shichishima; Hideyoshi Noji; Kazuhiko Ikeda; Kazuei Ogawa; Hideo Kimura; Yasuchika Takeishi; Junko Kimura
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients.

Authors:  Yayoi Shikama; Meiwan Cao; Tomoyuki Ono; Xiaomin Feng; Hideyoshi Noji; Hideo Kimura; Kazuei Ogawa; Yuko Suzuki; Kazuhiko Ikeda; Yasuchika Takeishi; Junko Kimura
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.